Netarsudil Mesylate Powder
NDC Package 70727-324-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Netarsudil Mesylate powders is netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). This formulation utilizes a powder delivery system. Marketed by Alcon Laboratories, Inc., this product is identified by NDC 70727-324.

Identification & Billing

NDC Package Code
70727-324-01
Package Description
150 g in 1 BOTTLE
Product Code
70727-324
11-Digit Billing Format
70727032401

Clinical Specifications

Proprietary Name
Netarsudil Mesylate
Non-Proprietary Name
Netarsudil Mesylate
Substance Name
Netarsudil Mesylate
Dosage Form
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s)
NETARSUDIL MESYLATE 1 g/g
Usage Information
Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness.

Regulatory & Marketing

Labeler Name
Alcon Laboratories, Inc.
Product Type
Bulk Ingredient
Marketing Category
BULK INGREDIENT - A category specifying that a product is marketed as a bulk ingredient.
Start Marketing Date
12-18-2017
Listing Expiration
12-31-2026
Exclude Flag
N
Unfinished Product
Yes
Sample Package
N/A

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70727-324-01 identifies a specific commercial package of 150 g in 1 bottle of Netarsudil Mesylate (UNFINISHED drug), a bulk ingredient labeled by Alcon Laboratories, Inc.. This powder is formulated for use and contains netarsudil mesylate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Alcon Laboratories, Inc. on December 18, 2017. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness.

How is this Alcon Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70727032401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70727-324-01
11-Digit CMS (5-4-2)
70727-0324-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.